Biologics Market
Biologics Global Strategic Business Report 2024: Market to Reach $656.8 Billion by 2030 with Recombinant Therapeutic Proteins Accounting for $246.6 Billion
June 17, 2024 10:47 ET | Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Biologics is estimated...
22157.jpg
$1.9 Billion Biopharmaceuticals Manufacturing Consumables Testing Market Report, 2034: Global and Regional Data Projections by Type, Raw Material, Application, and End-user
June 13, 2024 05:16 ET | Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Biopharmaceuticals Manufacturing Consumables Testing Market" report has been added to ResearchAndMarkets.com's offering.The global...
Global Biologics Safety Testing Market
Global Biologics Safety Testing Market to Surge to USD 7.2 Billion by 2029: Growth Driven by Advancements in Biopharmaceuticals, Monoclonal Antibodies Lead Market Applications
June 06, 2024 04:16 ET | Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Global Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin,...
22157.jpg
Wound Biologics Market Global Analysis and Forecast to 2030, Featuring Profiles of AlloSource, LifeNet Health, Smith & Nephew, Sanara MedTech, Mtf Biologics, Becton, Dickinson, MiMedx and TissueTech
June 06, 2024 04:13 ET | Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Wound Biologics Market - A Global and Regional Analysis: Focus on Product, Region, Country-Level Analysis, and Competitive Landscape Analysis and...
22157.jpg
Global Biosimilars and Follow-On Biologics Market Report 2024-2034 - Expanding the Portfolio of Biosimilars for Rare Diseases
May 31, 2024 06:46 ET | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars and Follow-On Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Biosimilars and...
axogen logo.jpg
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
May 28, 2024 16:30 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
22157.jpg
Key Growth Opportunities in Global Biotech Investment 2024: Acquiring Rare Disease-focused Biopharma Companies and Investing in Precision Medicine Platform Technology-based Biotech Companies
May 27, 2024 04:29 ET | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Biotech Investment, 2024" report has been added to ResearchAndMarkets.com's offering. In this analysis, the report...
axogen logo.jpg
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
May 16, 2024 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
22157.jpg
Microbiome Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 243 Agreements Signed Since 2016
May 07, 2024 07:35 ET | Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Microbiome Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Microbiome Collaboration and...
22157.jpg
Antibody Collaboration and Licensing Deals Analysis Report 2024 with Directory of 1,328 Agreements Signed Since 2019
May 07, 2024 06:05 ET | Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Antibody Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...